Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome

Canadian Journal of Diabetes

Volumn 42, Issue , 2018, Pages S10-S15

  Punthakee, Zubin ^a   Goldenberg, Ronald ^a   Katz, Pamela ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE CLASSIFICATION; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC SYNDROME X; MONOGENIC DIABETES; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; CLASSIFICATION; PRACTICE GUIDELINE; STANDARDS;

DIABETES MELLITUS; HUMANS; METABOLIC SYNDROME; PRACTICE GUIDELINES AS TOPIC; PREDIABETIC STATE;

EID: 85044748604     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2017.10.003     Document Type: Article

References (55)

1. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 35 (2012), S64–S71.
2. Amed, S., Oram, R., Maturity-Onset Diabetes of the Young (MODY): Making the right diagnosis to optimize treatment. Can J Diabetes 40 (2016), 449–454.
3. De Franco, E., Flanagan, S.E., Houghton, J.A., et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: An international cohort study. Lancet 386 (2015), 957–963.
4. Shields, B.M., Peters, J.L., Cooper, C., et al. Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open, 5, 2015, e009088.
5. Turner, R., Stratton, I., Horton, V., et al. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350 (1997), 1288–1293.
6. Fatima, A., Khawaja, K.I., Burney, S., et al. Type 1 and type 2 diabetes mellitus: Are they mutually exclusive?. Singapore Med J 54 (2013), 396–400.
7. Naylor, R., Philipson, L.H., Who should have genetic testing for maturity-onset diabetes of the young?. Clin Endocrinol (Oxf) 75 (2011), 422–426.
8. Patel, P., Macerollo, A., Diabetes mellitus: Diagnosis and screening. Am Fam Physician 81 (2010), 863–870.
9. Unger, R.H., Grundy, S., Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes. Diabetologia 28 (1985), 119–121.
10. Jones, A.G., Hattersley, A.T., The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30 (2013), 803–817.
11. Redondo, M.J., Rodriguez, L.M., Escalante, M., et al. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis. Pediatr Diabetes 14 (2013), 333–340.
12. Maldonado, M., Hampe, C.S., Gaur, L.K., et al. Ketosis-prone diabetes: Dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88 (2003), 5090–5098.
13. Oram, R.A., Patel, K., Hill, A., et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care 39 (2016), 337–344.
14. Sacks, D.B., Arnold, M., Bakris, G.L., et al. Executive summary: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 57 (2011), 793–798.
15. Nakagami, T., Takahashi, K., Suto, C., et al. Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy. Diabetes Res Clin Pract 124 (2017), 20–29.
16. McCance, D.R., Hanson, R.L., Charles, M.A., et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308 (1994), 1323–1328.
17. Engelgau, M.M., Thompson, T.J., Herman, W.H., et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 20 (1997), 785–791.
18. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997), 1183–1197.
19. The International Expert Committee, International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32 (2009), 1327–1334.
20. Sabanayagam, C., Khoo, E.Y., Lye, W.K., et al. Diagnosis of diabetes mellitus using HbA1c in Asians: Relationship between HbA1c and retinopathy in a multiethnic Asian population. J Clin Endocrinol Metab 100 (2015), 689–696.
21. Ito, C., Evidence for diabetes mellitus criteria in 2010 using HbA1c. Diabetol Int 4 (2013), 9–15 https://link.springer.com/article/10.1007/s13340-012-0086-7.
22. Kowall, B., Rathmann, W., HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?. Diabetes Metab Syndr Obes 6 (2013), 477–491.
23. Sarwar, N., Aspelund, T., Eiriksdottir, G., et al. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med, 7, 2010, e1000278.
24. Selvin, E., Steffes, M.W., Zhu, H., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362 (2010), 800–811.
25. International Diabetes Federation, Report of a World Health Organization Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93 (2011), 299–309 http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(11)00131-8/pdf.
26. Nielsen, A.A., Petersen, P.H., Green, A., et al. Changing from glucose to HbA1c for diabetes diagnosis: Predictive values of one test and importance of analytical bias and imprecision. Clin Chem Lab Med 52 (2014), 1069–1077.
27. Rosella, L.C., Lebenbaum, M., Fitzpatrick, T., et al. Prevalence of prediabetes and undiagnosed diabetes in Canada (2007–2011) according to fasting plasma glucose and HbA1c screening criteria. Diabetes Care 38 (2015), 1299–1305.
28. Karnchanasorn, R., Huang, J., Ou, H.Y., et al. Comparison of the current diagnostic criterion of HbA1c with fasting and 2-hour plasma glucose concentration. J Diabetes Res, 2016, 2016, 6195494.
29. Gallagher, E.J., Le Roith, D., Bloomgarden, Z., Review of hemoglobin A(1c) in the management of diabetes. J Diabetes 1 (2009), 9–17.
30. Yang, L., Shen, X., Yan, S., et al. HbA1c in the diagnosis of diabetes and abnormal glucose tolerance in patients with Graves’ hyperthyroidism. Diabetes Res Clin Pract 101 (2013), 28–34.
31. Son, J.I., Rhee, S.Y., Woo, J.T., et al. Hemoglobin A1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects. Diabetes Metab J 37 (2013), 343–348.
32. Attard, S.M., Herring, A.H., Wang, H., et al. Implications of iron deficiency/anemia on the classification of diabetes using HbA1c. Nutr Diabetes, 5, 2015, e166.
33. Cavagnolli, G., Pimentel, A.L., Freitas, P.A., et al. Factors affecting A1C in non-diabetic individuals: Review and meta-analysis. Clin Chim Acta 445 (2015), 107–114.
34. Bazo-Alvarez, J.C., Quispe, R., Pillay, T.D., et al. Glycated haemoglobin (HbA1c) and fasting plasma glucose relationships in sea-level and high-altitude settings. Diabet Med 34 (2017), 804–812.
35. Herman, W.H., Ma, Y., Uwaifo, G., et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 30 (2007), 2453–2457.
36. Ziemer, D.C., Kolm, P., Weintraub, W.S., et al. Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies. Ann Intern Med 152 (2010), 770–777.
37. Carson, A.P., Muntner, P., Selvin, E., et al. Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes. BMJ Open Diabetes Res Care, 4, 2016, e000213.
38. Cavagnolli, G., Pimentel, A.L., Freitas, P.A., et al. Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis. PLoS ONE, 12, 2017, e0171315.
39. Tsugawa, Y., Mukamal, K.J., Davis, R.B., et al. Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med 157 (2012), 153–159.
40. Davidson, M.B., Schriger, D.L., Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: Implications for the diagnosis of diabetes. Diabetes Res Clin Pract 87 (2010), 415–421.
41. Pani, L.N., Korenda, L., Meigs, J.B., et al. Effect of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care 31 (2008), 1991–1996.
42. Moran, A., Brunzell, C., Cohen, R.C., et al. Clinical care guidelines for cystic fibrosis–related diabetes. A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 33 (2010), 2697–2708.
43. Sacks, D.B., A1C versus glucose testing: A comparison. Diabetes Care 34 (2011), 518–523.
44. Christophi, C.A., Resnick, H.E., Ratner, R.E., et al. Confirming glycemic status in the Diabetes Prevention Program: Implications for diagnosing diabetes in high risk adults. J Diabetes Complications 27 (2013), 150–157.
45. Santaguida, P.L., Balion, C., Hunt, D., et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. 2005, Agency for Healthcare Research and Quality (AHRQ), Rockville Report No.: 05-E026-2 Contract No.: 128.
46. Huang, Y., Cai, X., Mai, W., et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis. BMJ, 355, 2016, i5953.
47. Warren, B., Pankow, J.S., Matsushita, K., et al. Comparative prognostic performance of definitions of prediabetes: A prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 5 (2016), 34–42.
48. Shaw, J.E., Zimmet, P.Z., Alberti, K.G., Point: Impaired fasting glucose: The case for the new American Diabetes Association criterion. Diabetes Care 29 (2006), 1170–1172.
49. Forouhi, N.G., Balkau, B., Borch-Johnsen, K., et al. The threshold for diagnosing impaired fasting glucose: A position statement by the European Diabetes Epidemiology Group. Diabetologia 49 (2006), 822–827.
50. Zhang, X., Gregg, E.W., Williamson, D.F., et al. A1C level and future risk of diabetes: A systematic review. Diabetes Care 33 (2010), 1665–1673.
51. Heianza, Y., Arase, Y., Fujihara, K., et al. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: The Toranomon Hospital Health Management Center Study 4 (TOPICS 4). Diabet Med 29 (2012), e279–e285.
52. Reaven, G.M., Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988), 1595–1607.
53. Alberti, K.G., Eckel, R.H., Grundy, S.M., et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (2009), 1640–1645.
54. Colagiuri, S., Lee, C.M., Wong, T.Y., et al. Glycemic thresholds for diabetes-specific retinopathy: Implications for diagnostic criteria for diabetes. Diabetes Care 34 (2011), 145–150.
55. Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med, 6, 2009, e1000097.